NCT06831929 HPV Ends Here: Increasing Uptake of the HPV Vaccine
| NCT ID | NCT06831929 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, Davis |
| Condition | HPV Vaccine |
| Study Type | INTERVENTIONAL |
| Enrollment | 2,232 participants |
| Start Date | 2025-02-28 |
| Primary Completion | 2026-02-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 2,232 participants in total. It began in 2025-02-28 with a primary completion date of 2026-02-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Develop, implement, and evaluate a culturally tailored multilevel intervention to increase uptake of the HPV vaccine among eligible patients ages 10-12 of the University of California, Davis Health Community Physician (UCDH CP) primary care practices using a randomized controlled trial design.
Eligibility Criteria
Inclusion Criteria: • Clinic patients between the ages of 10-12 who are eligible for the HPV vaccine Exclusion Criteria: • Clinic patients who already received the HPV vaccine or with any contraindication to the HPV vaccine.
Contact & Investigator
Julie HT Dang, PhD, MPH
PRINCIPAL INVESTIGATOR
University of California, Davis
Frequently Asked Questions
Who can join the NCT06831929 clinical trial?
This trial is open to participants of all sexes, aged 10 Years or older, up to 12 Years, studying HPV Vaccine. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06831929 currently recruiting?
Yes, NCT06831929 is actively recruiting participants. Contact the research team at jtdang@health.ucdavis.edu for enrollment information.
Where is the NCT06831929 trial being conducted?
This trial is being conducted at Sacramento, United States.
Who is sponsoring the NCT06831929 clinical trial?
NCT06831929 is sponsored by University of California, Davis. The principal investigator is Julie HT Dang, PhD, MPH at University of California, Davis. The trial plans to enroll 2,232 participants.